Insights

Global reach Azurity is a privately held global pharma player with a presence in more than 50 countries and a portfolio of over 50 medicines across 10 therapeutic areas, signaling opportunities for international distribution partnerships and co-marketing arrangements.

Strategic partnerships Recent and ongoing licensing and distribution deals with PolyPid for D-PLEX100 in the U.S. and Canada, plus a China distribution collaboration with Nang Kuang, indicate a strong appetite for exclusive or semi-exclusive partnerships that can be leveraged for additional products and geographies.

Nonadherence design CEO messaging and conference participation emphasize treating medication nonadherence as a design issue, suggesting opportunities to offer patient-centric delivery solutions, adherence analytics services, and digital engagement platforms to reduce drop-off.

Launch readiness Upcoming U S and Canada launch of D-PLEX100 in early 2027, contingent on approval, presents a near-term sales window for related surgical infection prevention products, post-market support programs, and bundled service offerings.

Supply chain confidence C-suite participation at industry events and a focus on supply integrity align with opportunities to propose end-to-end supply chain solutions, serialization or track-and-trace services, and strategic partnerships that enhance reliability for hospital networks and distributors.

Similar companies to Azurity Pharmaceuticals

Azurity Pharmaceuticals Tech Stack

Azurity Pharmaceuticals uses 8 technology products and services including Microsoft Clarity, Docker, DBT, and more. Explore Azurity Pharmaceuticals's tech stack below.

Media & News

Azurity Pharmaceuticals's Email Address Formats

Azurity Pharmaceuticals uses at least 3 email formats:
Azurity Pharmaceuticals Email FormatsExamplePercentage
FLast@azurity.comJDoe@azurity.com
59%
First.Last@azurity.comJohn.Doe@azurity.com
39%
Last@azurity.comDoe@azurity.com
2%

Frequently Asked Questions

What is Azurity Pharmaceuticals's phone number?

Minus sign iconPlus sign icon
You can contact Azurity Pharmaceuticals's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Azurity Pharmaceuticals's official website and social media links?

Minus sign iconPlus sign icon
Azurity Pharmaceuticals's official website is azurity.com and has social profiles on LinkedIn and Crunchbase.

How much revenue does Azurity Pharmaceuticals generate?

Minus sign iconPlus sign icon
As of October 2026, Azurity Pharmaceuticals's annual revenue is estimated to be $500M - $1B.

What is Azurity Pharmaceuticals's NAICS code?

Minus sign iconPlus sign icon
Azurity Pharmaceuticals's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Azurity Pharmaceuticals have currently?

Minus sign iconPlus sign icon
As of October 2026, Azurity Pharmaceuticals has approximately 1.1K employees across 3 continents, including North America, Asia and Europe. Key team members include Chief Medical Officer: V. G. D. L., Chief People Officer: P. D. and Chief Quality Officer: F. F. Explore Azurity Pharmaceuticals's employee directory with LeadIQ.

What industry does Azurity Pharmaceuticals belong to?

Minus sign iconPlus sign icon
Azurity Pharmaceuticals operates in the Pharmaceutical Manufacturing industry.

What technology does Azurity Pharmaceuticals use?

Minus sign iconPlus sign icon
Azurity Pharmaceuticals's tech stack includes Microsoft Clarity, Docker, DBT, Amazon Simple Email Service, Microsoft 365, Microsoft Dynamics, OpenAI and Atlassian Jira.

What is Azurity Pharmaceuticals's email format?

Minus sign iconPlus sign icon
Azurity Pharmaceuticals's email format typically follows the pattern of FLast@azurity.com. Find more Azurity Pharmaceuticals email formats with LeadIQ.

How much funding has Azurity Pharmaceuticals raised to date?

Minus sign iconPlus sign icon
As of October 2026, Azurity Pharmaceuticals has raised $40M in funding. The last funding round occurred on Jan 06, 2015.
Azurity Pharmaceuticals logo

Azurity Pharmaceuticals

Pharmaceutical ManufacturingMassachusetts, United States1001-5000 Employees

Azurity Pharmaceuticals is a privately held global pharmaceutical manufacturer based at 8 Cabot Road in Woburn, Massachusetts, United States, employing 501-1000 people. The company focuses on reformulating, adapting, and developing therapies to address unmet needs of overlooked patient populations, aiming to provide safe and usable treatment options. Its portfolio comprises more than 50 medicines across 10 therapeutic areas. In 2025, Azurity completed the acquisition of Covis Pharma Group and announced the closure of its Wilmington, North Carolina manufacturing facility, with about 75 employees affected. In February 2026, Audax Group invested in the company, joining other investors including HarbourVest and Pantheon.

Section iconCompany Overview

Phone number
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Employees
1001-5000

Section iconFunding & Financials

  • $40M

    Azurity Pharmaceuticals has raised a total of $40M of funding over 2 rounds. Their latest funding round was raised on Jan 06, 2015 as a Private Equity.

  • $500M - $1B

    Azurity Pharmaceuticals's revenue is estimated to be in the range of $500M - $1B

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.